- Home
- MAMA vs TECX Comparison
MAMA vs TECX Comparison
Compare MAMA & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- TECX
- Stock Information
- Founded
- MAMA 2010
- TECX 2019
- Country
- MAMA United States
- TECX United States
- Employees
- MAMA N/A
- TECX N/A
- Industry
- MAMA Specialty Foods
- TECX
- Sector
- MAMA Consumer Staples
- TECX
- Exchange
- MAMA Nasdaq
- TECX Nasdaq
- Market Cap
- MAMA 290.7M
- TECX 647.7M
- IPO Year
- MAMA N/A
- TECX 2018
- Fundamental
- Price
- MAMA $7.67
- TECX $45.69
- Analyst Decision
- MAMA Strong Buy
- TECX Strong Buy
- Analyst Count
- MAMA 3
- TECX 5
- Target Price
- MAMA $10.67
- TECX $72.25
- AVG Volume (30 Days)
- MAMA 473.3K
- TECX 94.6K
- Earning Date
- MAMA 12-16-2024
- TECX 02-24-2025
- Dividend Yield
- MAMA N/A
- TECX N/A
- EPS Growth
- MAMA N/A
- TECX N/A
- EPS
- MAMA 0.08
- TECX N/A
- Revenue
- MAMA $116,468,000.00
- TECX N/A
- Revenue This Year
- MAMA $18.91
- TECX N/A
- Revenue Next Year
- MAMA $12.69
- TECX N/A
- P/E Ratio
- MAMA $91.21
- TECX N/A
- Revenue Growth
- MAMA 17.20
- TECX N/A
- 52 Week Low
- MAMA $4.17
- TECX $1.40
- 52 Week High
- MAMA $9.98
- TECX $53.41
- Technical
- Relative Strength Index (RSI)
- MAMA 39.03
- TECX 47.61
- Support Level
- MAMA $7.55
- TECX $42.83
- Resistance Level
- MAMA $9.83
- TECX $51.76
- Average True Range (ATR)
- MAMA 0.46
- TECX 3.58
- MACD
- MAMA -0.11
- TECX -0.42
- Stochastic Oscillator
- MAMA 17.27
- TECX 27.17
About MAMA Mama's Creations Inc.
Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.